Advanced Practice Nurse
Prescribers with Davis Edge
6th Edition
• Author(s)Teri Moser Woo; Wendy
L. Wright
TEST BANK
▪ The Foundation
▪ Pharmacotherapeutics with Single Drugs
▪ Pharmacotherapeutics with Multiple Drugs
▪ Special Drug Treatment Considerations
,Question 1
A family nurse practitioner (FNP) is establishing prescribing practices in
a new primary care clinic. Which action best demonstrates the
advanced practice registered nurse's (APRN's) professional
responsibility for safe prescribing?
A. Prescribing medications based primarily on colleague
recommendations to maintain consistency within the practice
B. Independently evaluating the patient, confirming the diagnosis,
considering evidence-based recommendations, and documenting the
rationale for the selected therapy
C. Delegating medication selection to the collaborating physician while
independently providing patient education
D. Limiting prescriptions to medications the APRN has prescribed
previously regardless of patient-specific factors
Correct Answer: B
Rationale: APRNs are accountable for independent clinical decision-
making within their scope of practice. Safe prescribing requires a
comprehensive assessment, accurate diagnosis, individualized
medication selection, evidence-based decision-making, and complete
documentation. Option A lacks individualized care. Option C
inappropriately shifts prescribing responsibility. Option D ignores
patient-specific clinical needs and evidence-based practice.
Question 2
An APRN evaluates a 62-year-old patient with hypertension, chronic
kidney disease, and osteoarthritis. Before initiating pharmacotherapy,
which prescribing principle should receive the highest priority?
,A. Selecting the least expensive medication available
B. Choosing the medication with the newest FDA approval
C. Evaluating patient-specific factors including comorbidities, renal
function, current medications, and potential contraindications
D. Prescribing the medication with the greatest number of available
dosage forms
Correct Answer: C
Rationale: Evidence-based prescribing begins with evaluating the entire
clinical picture, including comorbid conditions, organ function,
concurrent medications, allergies, and contraindications. These factors
determine medication safety and effectiveness. Cost, formulation, and
novelty are secondary considerations after ensuring appropriate
therapy.
Question 3
A patient requests an antibiotic because symptoms of an upper
respiratory infection began 24 hours earlier. Physical examination
suggests a viral illness. What is the most appropriate APRN response?
A. Prescribe a broad-spectrum antibiotic to prevent secondary bacterial
infection.
B. Prescribe a narrow-spectrum antibiotic because it has fewer adverse
effects.
C. Explain that antibiotics are not indicated, recommend supportive
care, and provide return precautions.
D. Prescribe antibiotics only if the patient promises to discontinue them
after symptom improvement.
, Correct Answer: C
Rationale: Current U.S. antimicrobial stewardship principles
recommend avoiding antibiotics for uncomplicated viral infections.
APRNs should educate patients regarding the expected illness course,
provide symptomatic treatment recommendations, and advise when
reevaluation is warranted. Inappropriate antibiotic prescribing
contributes to antimicrobial resistance and unnecessary adverse
effects.
Question 4
An APRN is prescribing a medication with known teratogenic potential
for a reproductive-age woman. Which action is most appropriate
before initiating therapy?
A. Assume the patient is not pregnant if contraception is mentioned.
B. Discuss pregnancy intentions, assess pregnancy status when
appropriate, review contraceptive options, and counsel regarding fetal
risks.
C. Delay counseling until the first follow-up visit.
D. Avoid discussing reproductive health because it may offend the
patient.
Correct Answer: B
Rationale: Safe prescribing requires assessment of pregnancy potential,
discussion of reproductive goals, counseling regarding teratogenic risks,
and appropriate contraceptive planning before initiating medications
associated with fetal harm. This patient-centered approach supports
informed decision-making and medication safety.